Live Breaking News & Updates on Xilio therapeutics inc

Stay informed with the latest breaking news from Xilio therapeutics inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Xilio therapeutics inc and stay connected to the pulse of your community

Short Interest in Xilio Therapeutics, Inc. (NASDAQ:XLO) Increases By 600.2%

Xilio Therapeutics, Inc. (NASDAQ:XLO – Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 379,500 shares, an increase of 600.2% from the March 31st total of 54,200 shares. Based on an average trading volume of 1,170,000 shares, […]

Gilead-sciences-inc , Xilio-therapeutics-company-profile , Xilio-therapeutics-inc , Nasdaq , Xilio-therapeutics , Get-free-report , Gilead-sciences , Free-report , Xilio-therapeutics-daily , Nasdaq-xlo , Xlo

Gilead Sciences Announces First Quarter 2024 Financial Results

25.04.2024 - Gilead Sciences, Inc. (Nasdaq: GILD) announced today its first quarter 2024 results of operations. “Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, ...

Foster-city , California , United-states , Ireland , America , Complera-eviplera , Kevin-lofton , Sofosbuvir-velpatasvir , Anthony-welters , European-union , Immunomedics-inc , Xilio-therapeutics-inc

Xilio Therapeutics, Inc. (NASDAQ:XLO) Major Shareholder Purchases $368,790.00 in Stock

Xilio Therapeutics, Inc. (NASDAQ:XLO – Get Free Report) major shareholder Gilead Sciences, Inc. acquired 485,250 shares of the business’s stock in a transaction dated Tuesday, April 2nd. The stock was purchased at an average price of $0.76 per share, for a total transaction of $368,790.00. Following the completion of the acquisition, the insider now owns […]

United-states , America , Trustees-of-columbia-university , Xilio-therapeutics-inc , America-corp , Nasdaq , Gilead-sciences-inc , Bridgeway-capital-management , Vanguard-group-inc , Xilio-therapeutics-company-profile , Xilio-therapeutics

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket - Doma Holdings (NYSE:DOMA)

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading

Josh-siegler , Ch-auto-technology , Doma-holdings-inc , Sintx-technologies-inc , Holdings-co-ltd , Vivos-therapeutics-inc , Torrid-holdings-inc , Therapeutics-inc , Xilio-therapeutics-inc , Cleanspark-inc , Zapata-computing-holdings-inc , Sunshine-biopharma-inc

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results

On track with plans to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with microsatellite stable colorectal cancer in the...

Rock-springs , California , United-states , China , San-diego , American , Melissa-forst , Dan-budwick , Xilio-therapeutics-inc , American-association-for-cancer-research , Roche-group , Research-development-rd-expenses

Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session - AMC Enter Hldgs (NYSE:AMC), AEON Biopharma (AMEX:AEON)

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.

Israel , South-africa , Brazil , Israeli , Brian-gong , Josh-siegler , Nelsonc-chan , David-larsen , David-macdonald , Meta-materials-inc , Disc-medicine-inc , Cantor-fitzgerald

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

China , Foster-city , California , United-states , Gilead-sciences , Oncology-clinical-development , Linkedin-xilio-therapeutics-inc , Exchange-commission , Gilead-sciences-inc , Xilio-therapeutics-inc , Nasdaq

Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing

Announces strategic portfolio reprioritization focused on rapid advancement of clinical-stage programs for XTX301, a tumor-activated, IL-12, and XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, and...

China , United-states , Melissa-forst , Dan-budwick , Linkedin-xilio-therapeutics-inc , Pacific-western-bank-pacwest , Exchange-commission , Xilio-therapeutics-inc , Roche-group , Genentech-united-states-inc , Bain-capital-life-sciences , Gilead-sciences-inc

Gilead, Xilio Announce Exclusive License Agreement For Tumor-Activated IL-12 Program XTX301

Gilead, Xilio Announce Exclusive License Agreement For Tumor-Activated IL-12 Program XTX301
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Dennis-riedl , Gilead-sciences-inc , Xilio-therapeutics-inc , Xilio-therapeutics ,

Xilio Therapeutics (XLO) Announces $11.3 Million Private Placement Equity Financing, License Agreement with Gilead (GILD)

Xilio Therapeutics (XLO) Announces $11.3 Million Private Placement Equity Financing, License Agreement with Gilead (GILD)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nasdaq , Gilead-sciences-inc , Bain-capital-life-sciences , Pacific-western-bank-pacwest , Xilio-therapeutics-inc , Xilio-therapeutics , Rock-springs-capital , License-agreement , Gilead-sciences , Pacific-western-bank ,